Overview
Henry Holcomb is a Psychiatrist and a Neurologist in Kensington, Maryland. Dr. Holcomb is highly rated in 1 condition, according to our data. His top area of expertise is Schizophrenia.
His clinical research consists of co-authoring 8 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Pavel Klein is a Neurologist in Bethesda, Maryland. Dr. Klein is highly rated in 21 conditions, according to our data. His top areas of expertise are Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, and Post-Traumatic Epilepsy.
Johns Hopkins Outpatient Center
Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the Johns Hopkins Comprehensive Neurofibromatosis Center and director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care. Dr. Blakeley is highly rated in 27 conditions, according to our data. Her top areas of expertise are Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy.
MedStar Health Headache Center At McLean
Fernando Pagan is a Neurologist in Mclean, Virginia. Dr. Pagan is highly rated in 16 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Movement Disorders, Lewy Body Dementia (LBD), Benign Essential Blepharospasm, and Deep Brain Stimulation.
Frequently Asked Questions about Dr. Henry H. Holcomb
How do I make an appointment with Dr. Henry H. Holcomb?
You can book an appointment with Dr. Henry H. Holcomb by calling their office at 301-785-4799. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Henry H. Holcomb a top-rated expert for Schizophrenia?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Henry H. Holcomb is classified as an Advanced expert for Schizophrenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Henry H. Holcomb specialize in?
While Dr. Henry H. Holcomb is a Psychiatry, they have specific expertise in Schizophrenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.
Does Dr. Henry H. Holcomb participate in research or clinical trials?
Yes. Dr. Henry H. Holcomb has published 8 articles and abstracts on conditions like Schizophrenia. You can view a list of Dr. Henry H. Holcomb's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Henry H. Holcomb accept my insurance?
Dr. Henry H. Holcomb accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 301-785-4799 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers